ALPCO Launches Analytically Specific Human and Rodent STELLUX®

Glucagon ELISA

ALPCO's new STELLUX® Chemiluminescence Glucagon ELISA features increased analytical

specificity and a broad range to accurately quantify glucagon levels between 0.86 and 143.7 pmol/L
(3-500 pg/mL) in human and rodent samples.

Salem, NH, November 06, 2019 --(PR.com)-- ALPCO, a leading developer and manufacturer of life
science test solutions to advance research and improve clinical outcomes, announced the official launch
of its STELLUX® Chemi Glucagon ELISA. The new chemiluminescence ELISA features increased
analytical specificity and a broad range to accurately quantify glucagon levels between 0.86 and 143.7
pmol/L (3-500 pg/mL) in human and rodent samples.

Glucagon is a hormone with many functions including playing an essential role in energy homeostasis by
acting as a counterregulatory balance to insulin via the insulin:glucagon ratio (IGR). Researchers are
highly interested in investigating the possible connections between glucagon, pancreatic alpha cell
function, and the pathophysiology of diseases such as diabetes mellitus.

“We found that commercially available glucagon assays cross-react with oxyntomodulin, glicentin, and
other proglucagon peptides. In addition, researchers testing these assays often reported higher
cross-reactivity values than the manufacturers, creating challenges for investigators,” explains ALPCO's
president, Sean Conley. “We know that analytical specificity matters to our customers, so we designed
the STELLUX® Chemi Glucagon ELISA to address this need and provide a superior tool for
laboratories. We are confident this assay will empower users to further their glucagon research.”

The STELLUX® Chemi Glucagon ELISA exhibits high analytical specificity with 100% reactivity to
glucagon and does not cross-react with other proglucagon peptides like oxyntomodulin, glicentin and
incretin hormones such as glucagon-like peptide-1 and gastric inhibitory polypeptide. This assay has been
validated for the measurement of glucagon in mouse, rat, and human EDTA plasma samples as well as
cell culture. Additionally, it requires only 25 µL of sample to measure low, physiologically relevant
concentrations in both rodents and humans.

Download ALPCO's white paper How Differences in Analytical Specificity Contribute to Final
Calculated Concentrations of Glucagon in EDTA Plasma to learn more about the STELLUX® Chemi
Glucagon ELISA.

About ALPCO
American Laboratory Products Company (ALPCO) was founded in 1991 as an importer and distributor of
immunoassay-based products for the North American life science markets. The company has since grown
into a premier channel representing over 60 collaborating partners from around the globe. Today, ALPCO
offers a wide range of testing solutions, providing scientists and healthcare professionals with vital tools
for advancing research and improving quality of care.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
ALPCO
Robert Somogyi, PhD
1-800-592-5726
Contact via Email
www.alpco.com

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/798785

News Image:

Page 2/2
PR.com Press Release Distribution Terms of Use